I currently take rytary 4-5 times per day. My neuro thinks I may be a good candidate for this drug. In July 2023, thr drug manufacturer, Amneal,(if i understnd correctly) was working with FDA about safety of carbidopa in IPx203
parkinsonsnewstoday.com/ipx...
january 2024, knight Pharma obtained rights from Amneal to market IPX203 in Latin America and Canada .
parkinsonsnewstoday.com/new...
1. Does anyone have any experience with this drug, perhaps participated in trials,they would share?
2. I know that some people get Rx filled in Canada. Because prices are more reasonable. Does anyone think this may be an option for those of us from USA may do to get this drug?
3. Any thoughts on how long (those of us in USA) we must wait until fda approves ipx203?
4. I think when new drugs are initially available , they are cost prohibitive does anyone have thoughts on that?